Top Markets
#1 DogBull DogBull +54.40%
#2 Siren Siren +31.81%
#3 OriginTrail OriginTrail +15.19%
#4 Verus Coin Verus Coin +11.30%
#5 Tutorial Tutorial +8.83%
#6 Yield Basis Yield Basis +8.48%
#7 Prom Prom +8.33%
#8 Falcon Finance Falcon Finance +7.80%
#9 COTI COTI +7.42%
#10 Stargate Finance Stargate Finance +6.97%
Coin of the day
DogBull DogBull
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Lansen Pharmaceutical Holdings Limited Lansen Pharmaceutical Holdings Limited

Lansen Pharmaceutical Holdings Limited

0503
Clasificación en acciones #22050
Lansen Pharmaceutical Holdings Limited, an investment holding company,... Lansen Pharmaceutical Holdings Limited, an investment holding company, concentrates on the research, manufacturing, and global distribution of niche pharmaceutical drugs. These specialized medicines primarily address conditions in rheumatology and dermatology, serving both the People's Republic of China and international markets. The company's business operations are organized into three distinct divisions: Pharmaceuticals, Cosmetic Products, and Healthcare Products. Its product range includes generic traditional Chinese medicines, various cosmetic goods, and health-related items. Established in 2001, its main offices are situated in Ningbo, China. Lansen Pharmaceutical Holdings Limited operates as a subsidiary of Cathay International Pharma Manufacture and Distribution (China) Limited.
Precio por acción
$0.22961818
Última sincronización: 2023-12-18
Capitalización bursátil
$95.29M
Cambio (1 día)
0.16%
Cambio (1 año)
0.00%
País
CN
Comercio Lansen Pharmaceutical Holdings Limited (0503)

Categoría

Healthcare
Ingresos de Lansen Pharmaceutical Holdings Limited (0503)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Lansen Pharmaceutical Holdings Limited, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Lansen Pharmaceutical Holdings Limited desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN